Table: Brightpath Biotherapeutics -2018/19 parent results

BrightPath Biotherapeutics Co

10/05/2019 07:01

May 10 (Reuters)- 
          Brightpath Biotherapeutics Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2019    Mar 31, 2018    Mar 31, 2020      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales          155 mln         354 mln          4 mln                  
               (-56.0 pct)     (-33.1 pct)                               
  Operating     loss 1.67       loss 1.45       loss 2.42                
  Recurring     loss 1.68       loss 1.57       loss 2.42                
  Net           loss 1.88       loss 1.58       loss 2.44                
  EPS        loss 44.95 yen  loss 41.25 yen  loss 58.03 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T